These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

51 related articles for article (PubMed ID: 8645244)

  • 1. Identification of three separate binding sites on SHK toxin, a potent inhibitor of voltage-dependent potassium channels in human T-lymphocytes and rat brain.
    Pennington MW; Mahnir VM; Krafte DS; Zaydenberg I; Byrnes ME; Khaytin I; Crowley K; Kem WR
    Biochem Biophys Res Commun; 1996 Feb; 219(3):696-701. PubMed ID: 8645244
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synthetic ShK-like Peptide from the Jellyfish
    Kim YJ; Jo Y; Lee SE; Kim J; Choi JP; Lee N; Won H; Woo DH; Yum S
    Mar Drugs; 2024 May; 22(5):. PubMed ID: 38786608
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Structure-function relationships in ShKT domain peptides: ShKT-Ts1 from the sea anemone Telmatactis stephensoni.
    Sanches K; Ashwood LM; Olushola-Siedoks AA; Wai DCC; Rahman A; Shakeel K; Naseem MU; Panyi G; Prentis PJ; Norton RS
    Proteins; 2024 Feb; 92(2):192-205. PubMed ID: 37794633
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Native chemical ligation at Asx-Cys, Glx-Cys: chemical synthesis and high-resolution X-ray structure of ShK toxin by racemic protein crystallography.
    Dang B; Kubota T; Mandal K; Bezanilla F; Kent SB
    J Am Chem Soc; 2013 Aug; 135(32):11911-9. PubMed ID: 23919482
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Adeno-Associated virus 8 delivers an immunomodulatory peptide to mouse liver more efficiently than to rat liver.
    Wang Y; Hurley A; De Giorgi M; Tanner MR; Hu RC; Pennington MW; Lagor WR; Beeton C
    PLoS One; 2023; 18(4):e0283996. PubMed ID: 37040361
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Neurotoxins and pore forming toxins in sea anemones: Potential candidates for new drug development.
    Wang ZL; Zhang SY; Hao SL; Yang WX
    Histol Histopathol; 2023 Jan; 38(1):9-28. PubMed ID: 35880756
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synthetic hookworm-derived peptides are potent modulators of primary human immune cell function that protect against experimental colitis in vivo.
    Smallwood TB; Navarro S; Cristofori-Armstrong B; Watkins TS; Tungatt K; Ryan RYM; Haigh OL; Lutzky VP; Mulvenna JP; Rosengren KJ; Loukas A; Miles JJ; Clark RJ
    J Biol Chem; 2021 Jul; 297(1):100834. PubMed ID: 34051231
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Marine Toxins Targeting Kv1 Channels: Pharmacological Tools and Therapeutic Scaffolds.
    Finol-Urdaneta RK; Belovanovic A; Micic-Vicovac M; Kinsella GK; McArthur JR; Al-Sabi A
    Mar Drugs; 2020 Mar; 18(3):. PubMed ID: 32245015
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Kv1.3 Channel as a Key Therapeutic Target for Neuroinflammatory Diseases: State of the Art and Beyond.
    Wang X; Li G; Guo J; Zhang Z; Zhang S; Zhu Y; Cheng J; Yu L; Ji Y; Tao J
    Front Neurosci; 2019; 13():1393. PubMed ID: 31992966
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Conformational exchange in the potassium channel blocker ShK.
    Iwakawa N; Baxter NJ; Wai DCC; Fowler NJ; Morales RAV; Sugase K; Norton RS; Williamson MP
    Sci Rep; 2019 Dec; 9(1):19307. PubMed ID: 31848433
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tissue-Specific Venom Composition and Differential Gene Expression in Sea Anemones.
    Macrander J; Broe M; Daly M
    Genome Biol Evol; 2016 Aug; 8(8):2358-75. PubMed ID: 27389690
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bioactive Mimetics of Conotoxins and other Venom Peptides.
    Duggan PJ; Tuck KL
    Toxins (Basel); 2015 Oct; 7(10):4175-98. PubMed ID: 26501323
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Development of highly selective Kv1.3-blocking peptides based on the sea anemone peptide ShK.
    Pennington MW; Chang SC; Chauhan S; Huq R; Tajhya RB; Chhabra S; Norton RS; Beeton C
    Mar Drugs; 2015 Jan; 13(1):529-42. PubMed ID: 25603346
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A C-terminally amidated analogue of ShK is a potent and selective blocker of the voltage-gated potassium channel Kv1.3.
    Pennington MW; Harunur Rashid M; Tajhya RB; Beeton C; Kuyucak S; Norton RS
    FEBS Lett; 2012 Nov; 586(22):3996-4001. PubMed ID: 23063513
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expression and isotopic labelling of the potassium channel blocker ShK toxin as a thioredoxin fusion protein in bacteria.
    Chang SC; Galea CA; Leung EW; Tajhya RB; Beeton C; Pennington MW; Norton RS
    Toxicon; 2012 Oct; 60(5):840-50. PubMed ID: 22659540
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Analogs of the sea anemone potassium channel blocker ShK for the treatment of autoimmune diseases.
    Beeton C; Pennington MW; Norton RS
    Inflamm Allergy Drug Targets; 2011 Oct; 10(5):313-21. PubMed ID: 21824083
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Screening and cDNA cloning of Kv1 potassium channel toxins in sea anemones.
    Yamaguchi Y; Hasegawa Y; Honma T; Nagashima Y; Shiomi K
    Mar Drugs; 2010 Dec; 8(12):2893-905. PubMed ID: 21339955
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Engineering a stable and selective peptide blocker of the Kv1.3 channel in T lymphocytes.
    Pennington MW; Beeton C; Galea CA; Smith BJ; Chi V; Monaghan KP; Garcia A; Rangaraju S; Giuffrida A; Plank D; Crossley G; Nugent D; Khaytin I; Lefievre Y; Peshenko I; Dixon C; Chauhan S; Orzel A; Inoue T; Hu X; Moore RV; Norton RS; Chandy KG
    Mol Pharmacol; 2009 Apr; 75(4):762-73. PubMed ID: 19122005
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Peptide toxins in sea anemones: structural and functional aspects.
    Honma T; Shiomi K
    Mar Biotechnol (NY); 2006; 8(1):1-10. PubMed ID: 16372161
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 3.